Lenalidomide and Rituximab in Treating Patients With Non-Hodgkin Lymphoma
Clinical trial NCT00848328 · TERMINATED
Trial details
- NCT number
- NCT00848328
- Sponsor
- University of California, Davis
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-08-25
- Primary completion
- 2023-06-28
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.